Episode

E120: Real Life Use of PEXIVAS-Low

Podcast: The Evidence Based Rheumatology Podcast
Published: Mar 6, 2025
Duration seconds: 1473
Processing state: not_requested
Canonical source: https://msputman.podbean.com/e/e120-real-life-use-of-pexivas-low/
Audio: https://mcdn.podbean.com/mf/web/nny9dgf2sck6xxx2/120.mp3
JSON: /v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e120-real-life-use-of-pexivas-low
Markdown: /podcast/the-evidence-based-rheumatology-podcast-1130175/e120-real-life-use-of-pexivas-low.md

Actions

POST https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e120-real-life-use-of-pexivas-low/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e120-real-life-use-of-pexivas-low.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

What do you do when observational data and RCTs conflict? This week I'm covering the "real world PEXIVAS" study that was done by the French Vasculitis Study Group. Great read, interesting issues, have a listen and be sure to share with friends!